Kreido Laboratories has announced that Huntsman has purchased its STT Reactor System, marking the US company’s entrance into the European market. The STT is a system for manufacturing chemicals, pharmaceuticals and other biological products. It is designed to improve selectivity, increase yields and initiate novel chemistries and the technology is said to improve the efficiency, quality and speed of chemical processes and facilitate continuous manufacturing.